Showing results (91-100 of 116) with videos related to
Sort By:
Pageof 12
Oral Oncology|October 3, 2025
Patterns of care in de-novo oligo-metastatic and oligo-recurrent head and neck cancers: A Head and Neck Cancer International Group (HNCIG) SurveyMonali Swain, Sarbani Ghosh-Laskar, Lachlan McDowell, et al.Frontiers in Oncology|August 1, 2022
Intraindividual Comparison Between [18F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer PatientsIoana M Marinescu, Simon K B Spohn, Selina Kiefer, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 9, 2025
Comparison of survival and progression after focal- or whole brain radiotherapy in patients with primary CNS lymphoma - Results from a large multicenter analysis of the German Society of Radiation Oncology's Neuro-Radio-Oncology Working Group (DEGRO AG-NRO)Sina Heider, Luisa Allwohn, Alexander Rühle, et al.International Journal of Radiation Oncology, Biology, Physics|December 25, 2025
Prevalence and Prognostic Value of Individual T4-defining Radiologic Features in HPV-Positive Oropharyngeal CarcinomaMohd Hafiz Johari, Alexander Rühle, Jie Su, et al.The Laryngoscope|February 7, 2026
Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRTAlexander Rühle, Ranjan Subramani, Jie Su, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 12, 2024
Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and RadiosurgeryThomas B Brunner, Judit Boda-Heggemann, Daniel Bürgy, et al.Journal for Immunotherapy of Cancer|October 3, 2025
Abscopal effects in patients with malignant melanoma treated with radiotherapy and immune checkpoint inhibition: analysis of a large observational multicenter studySimone Ferdinandus, Alexander Rühle, Allison Lamrani, et al.Clinical and Translational Radiation Oncology|March 12, 2026
Radiotherapy in patients with NSCLC developing progressive disease during immune checkpoint inhibition: Abscopal responses and survivalJustus Kaufmann, Maike Trommer, Alexander Rühle, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 23, 2022
Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysisJohannes Roesch, Michael Oertel, Simone Wegen, et al.Oncoimmunology|January 12, 2026
Radiotherapy-induced abscopal effects in immune checkpoint inhibitor-refractory metastatic disease: results from a large multicenter real-world cohort studyMaike Trommer, Alexander Rühle, Allison Lamrani, et al.Pageof 12